COVID-19 Outpatient REGEN-COV Treatment is Now Available at Southeastern Med!
- Have you been exposed to COVID-19?
- Have you tested positive for COVID-19?
- Do you live in an institutional setting such as a nursing home or a group home?
If you answered “yes” to any of these questions, REGEN-COV might be right for you.
What is REGEN-COV (casirivimab/imdevimab-Regeneron Pharmaceuticals)?
Regen-Cov is a proven, effective, COVID-19 treatment, also known as monoclonal antibody therapy.
The treatment can reduce severe illness, hospitalization, and death risk by 70%, and reduces the odds of household contacts developing COVID-19 by 81%.
How do I find out if I meet criteria to receive the Regen-COV treatment?
Contact your primary care physician as soon as possible (the treatment is time sensitive).
Your physician will determine if this treatment is right for you and will submit an order to Southeastern Med for the treatment if indicated. Inclusion guidelines include:
- Treatment of mild to moderate COVID-19 in adult patients 18 years of age or older weighing at least 40 kg with positive results of direct SARS-CoV-2 viral testing, AND who are at HIGH RISK for progressing to severe COVID-19 and/or hospitalization. casirivimab/imdevimab should be given as soon as possible and within 10 days of symptom onset.
- REGEN-COV may be effective for use as post-exposure prophylaxis of COVID-19 in individuals who are at high risk for progression to severe COVID-19, including hospitalization or death
- REGEN-COV may only be used in adult for post-exposure prophylaxis of COVID-19 in individuals who are at high risk for progression to severe COVID-19, including hospitalization or death, AND are:
- – not fully vaccinated OR who are not expected to mount an adequate immune response to complete SARS-CoV-2 vaccination (for example, individuals with immunocompromising conditions including those taking immunosuppressive medications) AND
- – have been exposed to an individual infected with SARS-CoV-2 consistent with close contact criteria per Centers for Disease Control and Prevention (CDC)
- – who are at high risk of exposure to an individual infected with SARS-CoV-2 because of occurrence of SARS-CoV-2 infection in other individuals in the same institutional setting (for example, nursing homes, prisons)
- High risk is defined as patients who meet at least one of the following criteria:
- BMI ≥25
- Chronic kidney disease
- Cardiovascular disease
- Sickle Cell Disease
- Neurodevelopmental Disorders
- Are ≥65 years of age
- Have immunosuppressive disease
- Medical-related technological dependence
- Are currently receiving immunosuppressive treatment
- Chronic obstructive pulmonary disease/other chronic respiratory disease
- Other conditions as outlined by CDC.GOElderly (65 yo or >)
- >40kg weight & positive
Receiving Regeneron Treatment
If your physician prescribes a Regeneron treatment, you will report to 1341 Clark Street:
By Appointment Only (Monday-Friday 7:30 am-3:00 pm).
Fax the physician’s order to 740-439-8352
When you report for your treatment, please make sure you have an identification card and your insurance information with you.